Cited by 243

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Garcia-Beltran, Wilfredo F., Lam, Evan C., St. Denis, Kerri, Nitido, Adam D., Garcia, Zeidy H., Hauser, Blake M., Feldman, Jared, Pavlovic, Maia N., Gregory, David J., Poznansky, Mark C., Sigal, Alex, Schmidt, Aaron G., Iafrate, A. John, Naranbhai, Vivek, Balazs, Alejandro B.·2021·Cell

DOI 10.1016/j.cell.2021.04.006

Published version of a preprint

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2021.04.006

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592 · cited 2×
“Both of these vaccines demonstrated >94% efficacy at preventing coronavirus disease 2019 (COVID-19) in phase III clinical studies performed in late 2020 in multiple countries (Polack et al. 2020; Baden et al. 2021).”
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Wang, P., Nair, M. S., Liu, L., Iketani, S., Luo, Y., Guo, Y., Wang, M., Yu, J., Zhang, B., Kwong, P. D., et al. (2021) · Nature · doi:10.1038/s41586-021-03398-2 · Cited by 2,312
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Cantuti-Castelvetri, L., Ojha, R., Pedro, L. D., Djannatian, M., Franz, J., Kuivanen, S., van der Meer, F., Kallio, K., Kaya, T., Anastasina, M., et al. (2020) · Science · doi:10.1126/science.abd2985 · Cited by 1,925
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Ju, B., Zhang, Q., Ge, J., Wang, R., Sun, J., Ge, X., Yu, J., Shan, S., Zhou, B., Song, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2380-z · Cited by 1,667 · cited 4×
“…now demonstrated a close correlation between neutralization titers measured against pseudovirus and live SARS-CoV-2 cultures (Wang et al., 2020; Ju et al., 2020; Pinto et al., 2020; Yang et al., 2020; Moore et al., 2004; Crawford et al., 2020; Riepler et al., 2020), it is unclear what impact…”
Influential
Spike mutation D614G alters SARS-CoV-2 fitness
Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., et al. (2021) · Nature · doi:10.1038/s41586-020-2895-3 · Cited by 1,558
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., et al. (2020) · Science · doi:10.1126/science.abd0831 · Cited by 1,253
Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies
Greaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · doi:10.1101/2020.12.31.425021 · Cited by 1,178 · cited 2×
“The P.2. variant, which contains an E484K mutation within the RBD region, was capable of signiﬁcantly reducing neutralization potency of fully vaccinated individuals, in line with what has been suggested by deep mutational scanning (Greaney et al., 2021a; Jangra et al., 2021).”
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
Greaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.02.003 · Cited by 1,178

Show all 18 references

Research works printed but not linked: 29

"AZD1222 Vaccine Met Primary Efficacy Endpoint in Preventing COVID-19." 2020. November 23, 2020. https://www.astrazeneca.com/media-centre/press- releases/2020/azd1222hlr.html.
Crawford, Katharine H. D., Rachel Eguia, Adam S. Dingens, Andrea N. Loes, Keara D. Malone, Caitlin R. Wolf, Helen Y. Chu, et al. 2020. "Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays." Viruses 12 (5). https://doi.org/10.3390/v12050513. Faria et al. 2021. "Genomic Characterisation of an Emergent SARS-CoV-2 Lineage in Manaus: Preliminary Findings." January 12, 2021. https://virological.org/t/genomic- characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586. · DOI
Galloway, Summer E., Prabasaj Paul, Duncan R. MacCannell, Michael A. Johansson, John T. Brooks, Adam MacNeil, Rachel B. Slayton, et al. 2021. "Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021." MMWR. Morbidity and Mortality Weekly Report 70 (3): 95–99.
Garcia-Beltran, Wilfredo F., Evan C. Lam, Michael G. Astudillo, Diane Yang, Tyler E. Miller, Jared Feldman, Blake M. Hauser, et al. 2021. "COVID-19-Neutralizing Antibodies Predict Disease Severity and Survival." Cell 184 (2): 476–88.e11.
The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.02.14.21251704doi: medRxiv preprint http://paperpile.com/b/hwn56Z/HIfBd http://paperpile.com/b/hwn56Z/HIfBd https://www.astrazeneca.com/media-centre/press-releases/2020/azd1222hlr.html https://www.astrazeneca.com/media-centre/press-releases/2020/azd1222hlr.html http://paperpile.com/b/hwn56Z/HIfBd http://paperpile.com/b/hwn56Z/9fqtK http://paperpile.com/b/hwn56Z/9fqtK http://paperpile.com/b/hwn56Z/9fqtK http://paperpile.com/b/hwn56Z/9fqtK http://paperpile.com/b/hwn56Z/42Kr http://paperpile.com/b/hwn56Z/42Kr http://paperpile.com/b/hwn56Z/42Kr http://paperpile.com/b/hwn56Z/42Kr http://paperpile.com/b/hwn56Z/42Kr http://paperpile.com/b/hwn56Z/42Kr http://paperpile.com/b/hwn56Z/AXK7 http://paperpile.com/b/hwn56Z/AXK7 http://paperpile.com/b/hwn56Z/AXK7 http://paperpile.com/b/hwn56Z/AXK7 http://paperpile.com/b/hwn56Z/AXK7 http://paperpile.com/b/hwn56Z/lts5N http://paperpile.com/b/hwn56Z/lts5N http://paperpile.com/b/hwn56Z/lts5N http://paperpile.com/b/hwn56Z/lts5N http://paperpile.com/b/hwn56Z/lts5N http://paperpile.com/b/hwn56Z/dg29i https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker http://paperpile.com/b/hwn56Z/dg29i http://paperpile.com/b/hwn56Z/qb1Q http://paperpile.com/b/hwn56Z/qb1Q http://paperpile.com/b/hwn56Z/qb1Q http://paperpile.com/b/hwn56Z/qb1Q http://paperpile.com/b/hwn56Z/qb1Q http://paperpile.com/b/hwn56Z/qb1Q http://dx.doi.org/10.3390/v12050513 http://paperpile.com/b/hwn56Z/qb1Q http://paperpile.com/b/hwn56Z/CvSS http://paperpile.com/b/hwn56Z/CvSS https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586 https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586 http://paperpile.com/b/hwn56Z/CvSS http://paperpile.com/b/hwn56Z/6LIqX http://paperpile.com/b/hwn56Z/6LIqX http://paperpile.com/b/hwn56Z/6LIqX http://paperpile.com/b/hwn56Z/6LIqX http://paperpile.com/b/hwn56Z/6LIqX http://paperpile.com/b/hwn56Z/6LIqX http://paperpile.com/b/hwn56Z/h747H http://paperpile.com/b/hwn56Z/h747H http://paperpile.com/b/hwn56Z/h747H http://paperpile.com/b/hwn56Z/h747H http://paperpile.com/b/hwn56Z/h747H http://paperpile.com/b/hwn56Z/tbJYp http://paperpile.com/b/hwn56Z/tbJYp http://paperpile.com/b/hwn56Z/tbJYp http://paperpile.com/b/hwn56Z/tbJYp http://paperpile.com/b/hwn56Z/tbJYp http://paperpile.com/b/hwn56Z/tbJYp http://paperpile.com/b/hwn56Z/tbJYp http://dx.doi.org/10.1101/2020.12.31.425021 http://paperpile.com/b/hwn56Z/tbJYp http://paperpile.com/b/hwn56Z/6QEPd http://paperpile.com/b/hwn56Z/6QEPd http://paperpile.com/b/hwn56Z/6QEPd http://paperpile.com/b/hwn56Z/6QEPd http://paperpile.com/b/hwn56Z/6QEPd http://paperpile.com/b/hwn56Z/6QEPd http://dx.doi.org/10.1101/2020.09.10.292078 http://paperpile.com/b/hwn56Z/6QEPd http://paperpile.com/b/hwn56Z/EpA5 http://paperpile.com/b/hwn56Z/EpA5 http://paperpile.com/b/hwn56Z/EpA5 https://www.statnews.com/2021/02/24/new-data-shed-light-on-efficacy-of-jjs-single-dose-vaccine-against-covid-19/ https://www.statnews.com/2021/02/24/new-data-shed-light-on-efficacy-of-jjs-single-dose-vaccine-against-covid-19/ http://paperpile.com/b/hwn56Z/EpA5 http://paperpile.com/b/hwn56Z/Kjw1 http://paperpile.com/b/hwn56Z/Kjw1 http://paperpile.com/b/hwn56Z/Kjw1 http://paperpile.com/b/hwn56Z/Kjw1 http://paperpile.com/b/hwn56Z/Kjw1 https://doi.org/10.1101/2021.02.14.21251704 http://creativecommons.org/licenses/by-nc-nd/4.0/ · DOI
Dinnon 3rd, Sarah R. Leist, et al. 2020. "SARS-CoV-2 D614G Variant Exhibits Efficient Replication Ex Vivo and Transmission in Vivo." Science 370 (6523): 1464–68.
Hu, Jie, Pai Peng, Kai Wang, Bei-Zhong Liu, Liang Fang, Fei-Yang Luo, Ai-Shun Jin, Ni Tang, and Ai-Long Huang. 2021. "Emerging SARS-CoV-2 Variants Reduce Neutralization Sensitivity to Convalescent Sera and Monoclonal Antibodies." Cold Spring Harbor Laboratory. https://doi.org/10.1101/2021.01.22.427749. · DOI
Jangra, Sonia, Chengjin Ye, Raveen Rathnasinghe, Daniel Stadlbauer, Florian Krammer, Viviana Simon, Luis Martinez-Sobrido, Adolfo Garcia-Sastre, and Michael Schotsaert. 2021. "The E484K Mutation in the SARS-CoV-2 Spike Protein Reduces but Does Not Abolish Neutralizing Activity of Human Convalescent and Post-Vaccination Sera." medRxiv : The Preprint Server for Health Sciences, January. https://doi.org/10.1101/2021.01.26.21250543. · DOI
Le Bert, Nina, Anthony T. Tan, Kamini Kunasegaran, Christine Y. L. Tham, Morteza Hafezi, Adeline Chia, Melissa Hui Yen Chng, et al. 2020. "SARS-CoV-2-Specific T Cell Immunity in Cases of COVID-19 and SARS, and Uninfected Controls." Nature 584 (7821): 457–62.
Legros, Vincent, Solène Denolly, Manon Vogrig, Bertrand Boson, Eglantine Siret, Josselin Rigaill, Sylvie Pillet, et al. 2021. "A Longitudinal Study of SARS-CoV-2-Infected Patients Reveals a High Correlation between Neutralizing Antibodies and COVID-19 Severity." Cellular & Molecular Immunology 18 (2): 318–27.
Lemieux, Jacob, Katherine J. Siddle, Bennett M. Shaw, Christine Loreth, Stephen Schaffner, Adrianne Gladden-Young, Gordon Adams, et al. 2020. "Phylogenetic Analysis of SARS- CoV-2 in the Boston Area Highlights the Role of Recurrent Importation and Superspreading Events." medRxiv : The Preprint Server for Health Sciences, August. https://doi.org/10.1101/2020.08.23.20178236. · DOI
Liu, Haolin, Qianqian Zhang, Pengcheng Wei, Zhongzhou Chen, Katja Aviszus, John Yang, Walter Downing, et al. 2021. "The Basis of a More Contagious 501Y.V1 Variant of SARS- COV-2." Cold Spring Harbor Laboratory. https://doi.org/10.1101/2021.02.02.428884. · DOI
Moore, Michael J., Tatyana Dorfman, Wenhui Li, Swee Kee Wong, Yanhan Li, Jens H. Kuhn, James Coderre, et al. 2004. "Retroviruses Pseudotyped with the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Efficiently Infect Cells Expressing Angiotensin- Converting Enzyme 2." Journal of Virology 78 (19): 10628–35.
The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.02.14.21251704doi: medRxiv preprint http://paperpile.com/b/hwn56Z/Kjw1 http://paperpile.com/b/hwn56Z/Rf3z1 http://paperpile.com/b/hwn56Z/Rf3z1 http://paperpile.com/b/hwn56Z/Rf3z1 http://paperpile.com/b/hwn56Z/Rf3z1 http://paperpile.com/b/hwn56Z/Rf3z1 http://paperpile.com/b/hwn56Z/8xEEs http://paperpile.com/b/hwn56Z/8xEEs http://paperpile.com/b/hwn56Z/8xEEs http://paperpile.com/b/hwn56Z/8xEEs http://paperpile.com/b/hwn56Z/8xEEs http://paperpile.com/b/hwn56Z/8xEEs http://dx.doi.org/10.1101/2021.01.22.427749 http://paperpile.com/b/hwn56Z/8xEEs http://paperpile.com/b/hwn56Z/B95jI http://paperpile.com/b/hwn56Z/B95jI http://paperpile.com/b/hwn56Z/B95jI http://paperpile.com/b/hwn56Z/B95jI http://paperpile.com/b/hwn56Z/B95jI http://paperpile.com/b/hwn56Z/B95jI http://paperpile.com/b/hwn56Z/B95jI http://paperpile.com/b/hwn56Z/B95jI http://dx.doi.org/10.1101/2021.01.26.21250543 http://paperpile.com/b/hwn56Z/B95jI http://paperpile.com/b/hwn56Z/c7qJ http://paperpile.com/b/hwn56Z/c7qJ http://paperpile.com/b/hwn56Z/c7qJ http://paperpile.com/b/hwn56Z/c7qJ http://paperpile.com/b/hwn56Z/c7qJ http://paperpile.com/b/hwn56Z/3MDwa http://paperpile.com/b/hwn56Z/3MDwa http://paperpile.com/b/hwn56Z/3MDwa http://paperpile.com/b/hwn56Z/3MDwa http://paperpile.com/b/hwn56Z/3MDwa http://paperpile.com/b/hwn56Z/3MDwa http://paperpile.com/b/hwn56Z/UinE7 http://paperpile.com/b/hwn56Z/UinE7 http://paperpile.com/b/hwn56Z/UinE7 http://paperpile.com/b/hwn56Z/UinE7 http://paperpile.com/b/hwn56Z/UinE7 http://paperpile.com/b/hwn56Z/V5QUl http://paperpile.com/b/hwn56Z/V5QUl http://paperpile.com/b/hwn56Z/V5QUl http://paperpile.com/b/hwn56Z/V5QUl http://paperpile.com/b/hwn56Z/V5QUl http://paperpile.com/b/hwn56Z/V5QUl http://paperpile.com/b/hwn56Z/qkBP5 http://paperpile.com/b/hwn56Z/qkBP5 http://paperpile.com/b/hwn56Z/qkBP5 http://paperpile.com/b/hwn56Z/qkBP5 http://paperpile.com/b/hwn56Z/qkBP5 http://paperpile.com/b/hwn56Z/qkBP5 http://paperpile.com/b/hwn56Z/qkBP5 http://dx.doi.org/10.1101/2020.08.23.20178236 http://paperpile.com/b/hwn56Z/qkBP5 http://paperpile.com/b/hwn56Z/CiVcj http://paperpile.com/b/hwn56Z/CiVcj http://paperpile.com/b/hwn56Z/CiVcj http://paperpile.com/b/hwn56Z/CiVcj http://paperpile.com/b/hwn56Z/CiVcj http://dx.doi.org/10.1101/2021.02.02.428884 http://paperpile.com/b/hwn56Z/CiVcj http://paperpile.com/b/hwn56Z/szOdY http://paperpile.com/b/hwn56Z/szOdY https://www.the-scientist.com/news-opinion/moderna-developing-booster-shot-for-new-virus-variant-b-1-351-68384 https://www.the-scientist.com/news-opinion/moderna-developing-booster-shot-for-new-virus-variant-b-1-351-68384 http://paperpile.com/b/hwn56Z/szOdY http://paperpile.com/b/hwn56Z/P2rT http://paperpile.com/b/hwn56Z/P2rT http://paperpile.com/b/hwn56Z/P2rT http://paperpile.com/b/hwn56Z/P2rT http://paperpile.com/b/hwn56Z/P2rT http://paperpile.com/b/hwn56Z/P2rT http://paperpile.com/b/hwn56Z/ReOyr http://paperpile.com/b/hwn56Z/ReOyr http://paperpile.com/b/hwn56Z/ReOyr http://paperpile.com/b/hwn56Z/ReOyr http://paperpile.com/b/hwn56Z/ReOyr http://paperpile.com/b/hwn56Z/ReOyr http://dx.doi.org/10.1126/science.abg6105 http://paperpile.com/b/hwn56Z/ReOyr http://paperpile.com/b/hwn56Z/PDnnN http://paperpile.com/b/hwn56Z/PDnnN https://virological.org/t/sars-cov-2-reinfection-by-the-new-variant-of-concern-voc-p-1-in-amazonas-brazil/596 https://virological.org/t/sars-cov-2-reinfection-by-the-new-variant-of-concern-voc-p-1-in-amazonas-brazil/596 http://paperpile.com/b/hwn56Z/PDnnN http://paperpile.com/b/hwn56Z/dyr9H https://doi.org/10.1101/2021.02.14.21251704 http://creativecommons.org/licenses/by-nc-nd/4.0/ · DOI
Mendes, Renato Santana de Aguiar, Marta Giovanetti, and Bruno Solano de Freitas Souza. 2021. "Genomic Evidence of a Sars-Cov-2 Reinfection Case With E484K Spike Mutation in Brazil," January. https://doi.org/10.20944/preprints202101.0132.v1. · DOI
Oude Munnink, Bas B., Reina S. Sikkema, David F. Nieuwenhuijse, Robert Jan Molenaar, Emmanuelle Munger, Richard Molenkamp, Arco van der Spek, et al. 2021. "Transmission of SARS-CoV-2 on Mink Farms between Humans and Mink and back to Humans." Science 371 (6525): 172–77.
Paiva, Marcelo Henrique Santos, Duschinka Ribeiro Duarte Guedes, Cássia Docena, Matheus Filgueira Bezerra, Filipe Zimmer Dezordi, Laís Ceschini Machado, Larissa Krokovsky, et al. 2020. "Multiple Introductions Followed by Ongoing Community Spread of SARS-CoV-2 at One of the Largest Metropolitan Areas of Northeast Brazil." Viruses 12 (12). https://doi.org/10.3390/v12121414. · DOI
Pinto, Dora, Young-Jun Park, Martina Beltramello, Alexandra C. Walls, M. Alejandra Tortorici, Siro Bianchi, Stefano Jaconi, et al. 2020. "Structural and Functional Analysis of a Potent Sarbecovirus Neutralizing Antibody." bioRxiv : The Preprint Server for Biology, April. https://doi.org/10.1101/2020.04.07.023903. · DOI · Paper page
Rees-Spear, C., L. Muir, S. A. Griffith, J. Heaney, Y. Aldon, J. L. Snitselaar, P. Thomas, et al. 2021. "The Impact of Spike Mutations on SARS-CoV-2 Neutralization." Cold Spring Harbor Laboratory. https://doi.org/10.1101/2021.01.15.426849. Resende et al. 2021. "Spike E484K Mutation in the First SARS-CoV-2 Reinfection Case Confirmed in Brazil, 2020." January 10, 2021. https://virological.org/t/spike-e484k-mutation- in-the-first-sars-cov-2-reinfection-case-confirmed-in-brazil-2020/584. · DOI
Santos, Jadson C., and Geraldo A. Passos. 2021. "The High Infectivity of SARS-CoV-2 B.1.1.7 Is Associated with Increased Interaction Force between Spike-ACE2 Caused by the Viral N501Y Mutation." Cold Spring Harbor Laboratory. https://doi.org/10.1101/2020.12.29.424708. · DOI
Shen, Xiaoying, Haili Tang, Charlene McDanal, Kshitij Wagh, Will Fischer, James Theiler, Hyejin Yoon, et al. 2021. "SARS-CoV-2 Variant B.1.1.7 Is Susceptible to Neutralizing Antibodies Elicited by Ancestral Spike Vaccines." bioRxiv : The Preprint Server for Biology, January. https://doi.org/10.1101/2021.01.27.428516. · DOI
Siebring-van Olst, Ellen, Christie Vermeulen, Renee X. de Menezes, Michael Howell, Egbert F. Smit, and Victor W. van Beusechem. 2013. "Affordable Luciferase Reporter Assay for Cell- Based High-Throughput Screening." Journal of Biomolecular Screening 18 (4): 453–61.
"South Africa Suspends Use of AstraZeneca's COVID-19 Vaccine after It Fails to Clearly Stop Virus Variant." 2021. February 7, 2021. https://www.sciencemag.org/news/2021/02/south- africa-suspends-use-astrazenecas-covid-19-vaccine-after-it-fails-clearly-stop.
Wang, Chunyan, Wentao Li, Dubravka Drabek, Nisreen M. A. Okba, Rien van Haperen, Albert D. M. E. Osterhaus, Frank J. M. van Kuppeveld, Bart L. Haagmans, Frank Grosveld, and Berend-Jan Bosch. 2020. "A Human Monoclonal Antibody Blocking SARS-CoV-2 Infection." Nature Communications 11 (1): 2251.
Wu, Kai, Anne P. Werner, Juan I. Moliva, Matthew Koch, Angela Choi, Guillaume B. E. Stewart- Jones, Hamilton Bennett, et al. 2021. "mRNA-1273 Vaccine Induces Neutralizing Antibodies against Spike Mutants from Global SARS-CoV-2 Variants." bioRxiv : The Preprint Server for Biology, January. https://doi.org/10.1101/2021.01.25.427948. · DOI · Paper page
Yurkovetskiy, Leonid, Xue Wang, Kristen E. Pascal, Christopher Tomkins-Tinch, Thomas P. Nyalile, Yetao Wang, Alina Baum, et al. 2020a. "Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant." Cell 183 (3): 739–51.e8.
Yurkovetskiy, Leonid, Xue Wang, Kristen E. Pascal, Christopher Tomkins-Tinch, Thomas Nyalile, Yetao Wang, Alina Baum, et al. 2020b. "SARS-CoV-2 Spike Protein Variant D614G Increases Infectivity and Retains Sensitivity to Antibodies That Target the Receptor Binding Domain." bioRxiv : The Preprint Server for Biology, July. https://doi.org/10.1101/2020.07.04.187757. · DOI
Zhou, Bin, Tran Thi Nhu Thao, Donata Hoffmann, Adriano Taddeo, Nadine Ebert, Fabien Labroussaa, Anne Pohlmann, et al. 2020. "SARS-CoV-2 Spike D614G Variant Confers Enhanced Replication and Transmissibility." bioRxiv : The Preprint Server for Biology, October. https://doi.org/10.1101/2020.10.27.357558. · DOI
The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.02.14.21251704doi: medRxiv preprint http://paperpile.com/b/hwn56Z/Och4 http://paperpile.com/b/hwn56Z/Och4 http://dx.doi.org/10.21203/rs.3.rs-226857/v1 http://paperpile.com/b/hwn56Z/Och4 http://paperpile.com/b/hwn56Z/u2ik http://paperpile.com/b/hwn56Z/u2ik https://www.sciencemag.org/news/2021/02/south-africa-suspends-use-astrazenecas-covid-19-vaccine-after-it-fails-clearly-stop https://www.sciencemag.org/news/2021/02/south-africa-suspends-use-astrazenecas-covid-19-vaccine-after-it-fails-clearly-stop http://paperpile.com/b/hwn56Z/u2ik http://paperpile.com/b/hwn56Z/ureSv http://paperpile.com/b/hwn56Z/ureSv http://paperpile.com/b/hwn56Z/ureSv http://paperpile.com/b/hwn56Z/ureSv http://paperpile.com/b/hwn56Z/ureSv http://paperpile.com/b/hwn56Z/Am82 http://paperpile.com/b/hwn56Z/Am82 http://paperpile.com/b/hwn56Z/Am82 http://paperpile.com/b/hwn56Z/Am82 http://paperpile.com/b/hwn56Z/Am82 http://paperpile.com/b/hwn56Z/Am82 http://paperpile.com/b/hwn56Z/JjMqB http://paperpile.com/b/hwn56Z/JjMqB http://paperpile.com/b/hwn56Z/JjMqB http://paperpile.com/b/hwn56Z/JjMqB http://paperpile.com/b/hwn56Z/JjMqB http://paperpile.com/b/hwn56Z/JjMqB http://dx.doi.org/10.1101/2021.01.25.428137 http://paperpile.com/b/hwn56Z/JjMqB http://paperpile.com/b/hwn56Z/ig3Ke http://paperpile.com/b/hwn56Z/ig3Ke http://paperpile.com/b/hwn56Z/ig3Ke http://paperpile.com/b/hwn56Z/ig3Ke http://paperpile.com/b/hwn56Z/ig3Ke http://paperpile.com/b/hwn56Z/ig3Ke http://dx.doi.org/10.1101/2021.01.18.427166 http://paperpile.com/b/hwn56Z/ig3Ke http://paperpile.com/b/hwn56Z/sZ2t8 http://paperpile.com/b/hwn56Z/sZ2t8 http://paperpile.com/b/hwn56Z/sZ2t8 http://paperpile.com/b/hwn56Z/sZ2t8 http://paperpile.com/b/hwn56Z/sZ2t8 http://paperpile.com/b/hwn56Z/sZ2t8 http://dx.doi.org/10.1101/2021.01.25.427948 http://paperpile.com/b/hwn56Z/sZ2t8 http://paperpile.com/b/hwn56Z/HyOk http://paperpile.com/b/hwn56Z/HyOk http://paperpile.com/b/hwn56Z/HyOk http://paperpile.com/b/hwn56Z/HyOk http://paperpile.com/b/hwn56Z/HyOk http://paperpile.com/b/hwn56Z/HyOk http://dx.doi.org/10.1016/j.bsheal.2020.08.004 http://paperpile.com/b/hwn56Z/HyOk http://paperpile.com/b/hwn56Z/3x4zP http://paperpile.com/b/hwn56Z/3x4zP http://paperpile.com/b/hwn56Z/3x4zP http://paperpile.com/b/hwn56Z/3x4zP http://paperpile.com/b/hwn56Z/3x4zP http://paperpile.com/b/hwn56Z/FPkvJ http://paperpile.com/b/hwn56Z/FPkvJ http://paperpile.com/b/hwn56Z/FPkvJ http://paperpile.com/b/hwn56Z/FPkvJ http://paperpile.com/b/hwn56Z/FPkvJ http://paperpile.com/b/hwn56Z/FPkvJ http://paperpile.com/b/hwn56Z/FPkvJ http://dx.doi.org/10.1101/2020.07.04.187757 http://paperpile.com/b/hwn56Z/FPkvJ http://paperpile.com/b/hwn56Z/G433S http://paperpile.com/b/hwn56Z/G433S http://paperpile.com/b/hwn56Z/G433S http://paperpile.com/b/hwn56Z/G433S http://paperpile.com/b/hwn56Z/G433S http://paperpile.com/b/hwn56Z/G433S http://dx.doi.org/10.1101/2020.10.27.357558 http://paperpile.com/b/hwn56Z/G433S https://doi.org/10.1101/2021.02.14.21251704 http://creativecommons.org/licenses/by-nc-nd/4.0/ · DOI

Sorted by citations

SARS-CoV-2 variants, spike mutations and immune escape
Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., Ludden, C., Reeve, R., Rambaut, A., COVID-19 Genomics UK (COG-UK) Consortium, et al. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00573-0 · Cited by 3,528
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
Cele, S., Jackson, L., Khoury, D. S., Khan, K., Moyo-Gwete, T., Tegally, H., San, J. E., Cromer, D., Scheepers, C., Amoako, D., et al. (2021) · doi:10.1101/2021.12.08.21267417 · Cited by 1,333
Self-citation
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination
Goel, R. R., Apostolidis, S. A., Painter, M. M., Mathew, D., Pattekar, A., Kuthuru, O., Gouma, S., Hicks, P., Meng, W., Rosenfeld, A. M., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abi6950 · Cited by 655
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
Network for Genomic Surveillance in South Africa, Cele, S., COMMIT-KZN Team, Gazy, I., Jackson, L., Hwa, S.-H., Tegally, H., Lustig, G., Giandhari, J., Pillay, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03471-w · Cited by 651
Self-citation
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Motozono, C., Toyoda, M., Zahradnik, J., Saito, A., Nasser, H., Tan, T. S., Ngare, I., Kimura, I., Uriu, K., Kosugi, Y., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.006 · Cited by 586
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
Deng, X., Garcia-Knight, M. A., Khalid, M. M., Servellita, V., Wang, C., Morris, M. K., Sotomayor-González, A., Glasner, D. R., Reyes, K. R., Gliwa, A. S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.04.025 · Cited by 651
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
Gruell, H., Vanshylla, K., Tober-Lau, P., Hillus, D., Schommers, P., Lehmann, C., Kurth, F., Sander, L. E., & Klein, F. (2022) · Nature Medicine · doi:10.1038/s41591-021-01676-0 · Cited by 410
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
Lucas, C., Vogels, C. B. F., Yildirim, I., Rothman, J. E., Lu, P., Monteiro, V., Gehlhausen, J. R., Campbell, M., Silva, J., Tabachnikova, A., et al. (2021) · Nature · doi:10.1038/s41586-021-04085-y · Cited by 226
Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine
Goel, R. R., Painter, M. M., Lundgreen, K. A., Apostolidis, S. A., Baxter, A. E., Giles, J. R., Mathew, D., Pattekar, A., Reynaldi, A., Khoury, D. S., et al. (2022) · Cell · doi:10.1016/j.cell.2022.04.009 · Cited by 207
Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2
Israelow, B., Mao, T., Klein, J., Song, E., Menasche, B., Omer, S. B., & Iwasaki, A. (2021) · Science Immunology · doi:10.1126/sciimmunol.abl4509 · Cited by 189
Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2
Israelow, B., Mao, T., Klein, J., Song, E., Menasche, B., Omer, S. B., & Iwasaki, A. (2021) · doi:10.1101/2021.05.19.444825 · Cited by 189
SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63
Woldemeskel, B. A., Garliss, C. C., & Blankson, J. N. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149335 · Cited by 175
The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness
Kim, K., Calabrese, P., Wang, S., Qin, C., Rao, Y., Feng, P., & Chen, X. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-19067-x · Cited by 115
Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera
Tada, T., Zhou, H., Dcosta, B. M., Samanovic, M. I., Mulligan, M. J., & Landau, N. R. (2021) · iScience · doi:10.1016/j.isci.2021.103341 · Cited by 101
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
Naranbhai, V., Nathan, A., Kaseke, C., Berrios, C., Khatri, A., Choi, S., Getz, M. A., Tano-Menka, R., Ofoman, O., Gayton, A., et al. (2022) · Cell · doi:10.1016/j.cell.2022.03.022 · Cited by 88
Self-citation
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine
Low, J. G., de Alwis, R., Chen, S., Kalimuddin, S., Leong, Y. S., Mah, T. K. L., Yuen, N., Tan, H. C., Zhang, S. L., Sim, J. X. Y., et al. (2022) · npj Vaccines · doi:10.1038/s41541-022-00590-x · Cited by 61
Neutralization Potential of Covishield Vaccinated Individuals Sera Against B.1.617.1
Yadav, P. D., Sapkal, G. N., Abraham, P., Deshpande, G., Nyayanit, D. A., Patil, D. Y., Gupta, N., Sahay, R. R., Shete, A. M., Kumar, S., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab483 · Cited by 51
A phase 1/2 randomized, double-blinded, placebo controlled ascending dose trial to assess the safety, tolerability and immunogenicity of ARCT-021 in healthy adults
Low, J. G., de Alwis, R., Chen, S., Kalimuddin, S., Leong, Y. S., Mah, T. K. L., Yuen, N., Tan, H. C., Zhang, S. L., Sim, J. X. Y., et al. (2021) · doi:10.1101/2021.07.01.21259831 · Cited by 19

Authors: Garcia-Beltran, W. F., Lam, E. C., St. Denis, K., Nitido, A. D., Garcia, Z. H., Hauser, B. M., Feldman, J., Pavlovic, M. N., Gregory, D. J., Poznansky, M. C., Sigal, A., Schmidt, A. G., Iafrate, A. J., Naranbhai, V., & Balazs, A. B.
Venue: Cell
Publisher: Elsevier BV
Published: 2021-04
Volume: 184
Issue: 9
Pages: 2523
ISSN: 0092-8674
DOI: 10.1016/j.cell.2021.04.006
Cited by: 243
References: 18
Language: en
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 5 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks